Search
Mckesson Corp
MCKAdd to Watchlist
838.750USD
-14.960-1.75%
Close 08-20 16:00（ET）
100.71BMarket Cap
21.78P/E TTM
Forecast
Currency: USD Updated: 2026-08-19The current earnings forecast score of Mckesson Corp is 8.53, ranking 31 out of 158 in the Pharmaceuticals industry. The average price target is 955.00, with a high of 1000.00 and a low of 757.50.
Analyst Rating
Based on
20
analysts
Buy
Current Rating
979.827
Target Price
+12.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Mckesson Corp
MCK
20
Biogen Inc
BIIB
37
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Regeneron Pharmaceuticals Inc
REGN
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Mckesson Corp's expected revenue for the next quarter?
Mckesson Corp's expected revenue is 109.91B.
What is Mckesson Corp's price target?
Analysts forecast that Mckesson Corp's price target is USD 955.00, with the highest forecast at USD 1.00K and the lowest forecast at USD 757.50.
How have Mckesson CorpMCK's recent earnings per share performed?
The market expectation was USD 5.17, while Mckesson CorpMCK's earnings per share (EPS) for the previous quarter was USD 13.74. EPS for the next quarter is expected at USD 10.70.
What is the analyst rating for Mckesson Corp?
Based on the ratings of Mckesson Corp's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.